TABLE 3.
Results of four commercial real-time PCR assays used for investigation of 37 M. pneumoniae-positive respiratory tract samples compared to the in-house real-time PCR assay
Assay | No. of positive samples (n = 37) (%) | Crossing threshold of positive samples |
95% CIa | P valueb | |
---|---|---|---|---|---|
Mean ± SD | Range of means | ||||
In-house | 37 (100) | 30.80 ± 2.72 | 23.29–35.75 | 29.92–31.68 | |
Diagenode | 37 (100) | 31.50 ± 3.28 | 23.29–39.31 | 30.44–32.56 | ns |
GeneProof | 34 (91.9) | 30.80 ± 1.98 | 24.44–33.72 | 30.13–31.47 | ns |
Ingenetix | 35 (94.6) | 34.13 ± 2.94 | 26.41–40.85 | 33.16–35.10 | <0.001 |
LightMix | 35 (94.6) | 32.29 ± 3.05 | 24.32–37.86 | 31.28–33.30 | <0.001 |
95% CI, 95% confidence interval.
Calculated by paired Student's t test (only results of samples positive in both in-house and commercial assay were compared). ns, not significant.